In part 1 of this Exclusive Interview, Dr. Carla Greenbaum explains the mission of her research in relation to efforts to cure type 1 diabetes in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 2 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about predicting diabetes, the ability to test for diabetes antibiodies in very young children, and steps to treat the disease early.

In part 3 of this Exclusive Interview, Dr. Carla Greenbaum explains the reason for disease modifying therapy in a conversation with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California.

In part 4 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the benefits of gene therapy and early detection even without a therapy yet in place.

In part 5 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the importance of knowing the stages of diabetes.

In part 6 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about what health care providers can do for people with type 1.

In part 7 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about a diabetes vaccine and past efforts to treat those at risk.

In part 8 of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the diagnosis of diabetes in adults, as differentiated from diagnosis in children.

In part 9, the conclusion of this Exclusive Interview, Dr. Carla Greenbaum talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California about the realities of where diabetes research can be in the next five or more years, in relation to a cure as well as other types of treatments.